Similarly, Katsanos et al. reported that in samples from patients presenting within 6 h from symptoms onset, significantly raised median plasma GFAP concentrations detected in ICH vs. IS, stroke mimetics, and controls. This evidence concerns the gene GFAP and stroke disorder.